Avextra

Avextra, a German pharmaceutical company, develops and distributes clinically researched cannabis-based prescription medicines for patients in Europe with headquarters in Germany.

Here are key aspects of the company:

• Products & Services: The firm creates safe, effective, and authorized medicinal products utilizing the therapeutic potential of cannabinoids to treat chronic diseases.
• Innovation: Avextra dedicates one-third of its total budget to research and development to ensure product efficacy, quality, and an expanded evidence base for cannabis-based therapies.
• Operations: The company controls the entire value chain from plant cultivation in Portugal to GMP-certified manufacturing in Germany to guarantee supply security and consistent high quality.
• Locations: Operational activities span multiple countries including Portugal for agriculture, Germany for production, Great Britain for clinical clinics, and Europe for patient care initiatives.

Avextra combines a robust clinical study program with full vertical integration to deliver evidence-based medical cannabis solutions that improve the lives of patients suffering from chronic conditions.